Contact Us
Contact Us

News

News & Insights

The medical device registration application of Bonvadis® for all indications in wounds has been accepted by Egypt EDA.

/2025-04-28/

The medical device registration application of Bonvadis® for all indications in wounds has been accepted by Australia EDA.

/2025-04-16/

Oneness has submitted 510(k) application of Bonvadis® for full thickness wound indications to the U.S. FDA.

/2025-04-10/

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Brazil ANVISA. 

/2025-04-03/

Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis® from Brazil ANVISA.

/2025-03-25/

The medical device registration application of Bonvadis for all indications in wounds has been accepted by UAE MOHAP. 

/2025-03-18/
1 2
Events
2022-06-21

Oneness Biotech to attend SAWC Spring | WHS meeting in Dallas, USA

Lorem Ipsum is simply dummy text of the printing a...
Read More
2022-06-21

COVID19 Restrictions in Large Gatherings and Churches

Lorem Ipsum is simply dummy text of the printing a...
Read More
2022-06-21

A Possible Moratorium on Federal Death Roll Prisoners Execution

Lorem Ipsum is simply dummy text of the printing a...
Read More
2022-06-21

Oneness Biotech to attend SAWC Spring | WHS meeting in Dallas, USA

Lorem Ipsum is simply dummy text of the printing a...
Read More
2022-06-20

Oneness Listed in the S&P Global Sustainability Yearbook for Three Consecutive Years

Lorem Ipsum is simply dummy text of the printing a...
Read More
Media Gallery

Bonvadis Topical Cream (US Rx) Picture1

Bonvadis Topical Cream (US Rx) Picture1